31/05/2018
New cross-border Board reflects global potential of therapy
Asarina Pharma’s new Board reflects the global potential of its first-in-class therapy for PMDD. New members include senior pharma, science and research professionals from a range of countries contributing a powerful mix of skills. [...]
